Research at Children's
About Us
Research Administration
Our Facilities
Grants Funding
Annual Report
Give to Research
Our Research
Faculty
Education
Clinical Trials
Latest News
Careers
 
 
Email this page Email This Page
Print this page Print This Page
 

  Join Us On:
  Follow Children's on Facebook  Facebook
  Follow Children's on Twitter  Twitter
  Watch Children's on YouTube  YouTube
 
 
     
 

Institutional Review Board

The mission of the Institutional Review Board (IRB) and the Office for the Protection of Human Subjects (OPHS) is to protect the rights and welfare of research participants. The IRB is a committee consisting of scientists, non-scientists, and other people with sufficient expertise, not affiliated with Children's National Medical Center, who review and evaluate all research protocols, or studies, involving research with human participants.

Research protocols cannot be implemented without IRB review and approval. In addition, each study must be reviewed at least once per year to ensure that there have been no changes to the risks and benefits to participants. All research protocol alterations (e.g., change of Investigator, modification of procedures, or outcome measures) must also be reviewed and approved by the IRB.

Children's currently has four IRB committees. IRB 01 and IRB 04 are standard committees that are responsible for reviewing most protocol submissions. IRB 02 is convened when clinically urgent situations, unanticipated funding issues, or unusual scientific circumstances require a rapid IRB response.

The OPHS is the administrative and regulatory compliance arm of the IRB. It serves as the gatekeeper of all issues related to the protection of human research participants. OPHS acts as the liaison between the IRB committees and the research investigators, documents compliance with federal research regulations, and educates the Children's research community about the proper and ethical conduct of research involving human participants. Investigators, project coordinators, and others engaged in human subjects research are encouraged to work with the OPHS prior to submitting protocols to the IRB to smooth out the application process.


IRB Chair:
Naynesh R. Kamani, MD

IRB 01
Vice Chair: Jay Salpekar, MD

IRB 02 (Rapid Response)
Vice Chair: Tamara Rakusan, MD, Ph.D.
Alternate Vice Chair: Joan Conry, MD

IRB 04
Vice Chair: Edward Wong, MD


Contact Information:

OPHS Manager

Birdena Samuel, CIP
301-565-8488
bsamuel@childrensnational.org

AAHRPP & Education Manager
Maryann Rossi, Ph.D., CIM, CIP
301-565-8485 mrossi@childrensnational.org


OPHS Staff:

IRB Regulatory Analyst- Committee 01
301-565-8489

IRB Regulatory Analyst-Committee 04
301-565-8543

IRB Regulatory Analyst – Continuing Review
Jan Martinez, CIM, CIP
301-565-8542
jmartine@childrensnational.org

IRB Regulatory Specialist – Minimal Risk Research
301-565-8541

IRB Regulatory Specialist – Minimal Risk Research, Pediatric Central IRB (PCIRB)
Gloria Lawrence, CIM
301-565-8479
glawrenc@childrensnational.org
 


   
Children's National Medical Center |
111 Michigan Avenue, NW Washington, DC 20010 | 202-476-5000 | © 2013 & Privacy Statement